The role of N6-methyladenosine modification in tumor angiogenesis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.N6-methyladenosine (m6A) RNA modification influences tumor angiogenesis, impacting cancer growth and metastasis. Targeting m6A with anti-angiogenesis drugs offers a promising strategy to overcome drug resistance in cancer treatment.
Area Of Science
- Oncology
- Molecular Biology
- Epigenetics
Background
- Tumor angiogenesis is crucial for cancer progression, enabling growth, invasion, and metastasis.
- N6-methyladenosine (m6A) is a key RNA modification affecting RNA metabolism and gene expression.
- Aberrant m6A modification is implicated in various diseases, including cancer pathogenesis.
Purpose Of The Study
- To review the role of m6A modification in tumor angiogenesis.
- To elucidate the interactions between m6A and tumor angiogenesis pathways.
- To explore the potential of targeting m6A for anti-cancer therapy.
Main Methods
- Literature review of studies on m6A modification and tumor angiogenesis.
- Analysis of molecular mechanisms linking m6A to angiogenesis.
- Evaluation of therapeutic strategies involving m6A targeting.
Main Results
- m6A modification influences multiple molecules and pathways involved in tumor angiogenesis.
- m6A dysregulation promotes cancer development and progression.
- m6A regulates angiogenesis through various mechanisms impacting cancer malignancy.
Conclusions
- m6A modification plays a significant role in tumor angiogenesis.
- Targeting m6A in combination with anti-angiogenesis therapies presents a promising strategy for cancer treatment.
- This approach may help overcome challenges associated with drug resistance.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...